# K221129: CloudTMS for OCD

- Pathway: 510(k) (Traditional)
- Applicant: Teleemg, LLC
- Decided: Mar 10, 2023 after 326 days
- Product code: QCI (Transcranial Magnetic Stimulation System For Obsessive-Compulsive Disorder)
- Device class: 2
- Regulation: 21 CFR 882.5802
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 9 generations back to DEN070003 (2008). 16 ancestors in all.
1 later device descends from it; 1 cites it directly.
0 of 18 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K193006: MagVenture TMS Therapy – for treatment of OCD, MagVenture TMS Therapy system, Tonica Elektronik A/S (2020) Summary page 4.
- K160309: Neurosoft TMS, Teleemg, LLC (2016) Summary page 4.

## Most influential descendants
- K233742: CloudTMS Edge for OCD (2023), 0 descendants of its own

## Indications for use
The CloudTMS for OCD is intended to be used as an adjunct for the treatment of adult patients suffering from Obsessive-Compulsive Disorder (OCD).

Source page: https://510kreport.com/device/K221129
Methodology: https://510kreport.com/methodology